Assessing the impact of efficacy stopping rules on the error rates under the multi-arm multi-stage framework.

The multi-arm multi-stage design allows stopping for both lack-of-benefit on the intermediate outcome and efficacy on the definitive outcome at the interim stages. We provide guidelines on how to control the familywise error rate when efficacy boundaries are implemented in practice.